ZA766381B - New piperidine derivatives - Google Patents

New piperidine derivatives

Info

Publication number
ZA766381B
ZA766381B ZA766381A ZA766381A ZA766381B ZA 766381 B ZA766381 B ZA 766381B ZA 766381 A ZA766381 A ZA 766381A ZA 766381 A ZA766381 A ZA 766381A ZA 766381 B ZA766381 B ZA 766381B
Authority
ZA
South Africa
Prior art keywords
piperidine derivatives
new piperidine
new
derivatives
piperidine
Prior art date
Application number
ZA766381A
Other languages
English (en)
Inventor
M Thiel
K Stach
W Friebe
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA766381B publication Critical patent/ZA766381B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA766381A 1975-11-07 1976-10-25 New piperidine derivatives ZA766381B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ZA766381B true ZA766381B (en) 1977-10-26

Family

ID=5961166

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA766381A ZA766381B (en) 1975-11-07 1976-10-25 New piperidine derivatives

Country Status (20)

Country Link
US (1) US4243807A (en:Method)
JP (1) JPS6055509B2 (en:Method)
AT (1) AT352726B (en:Method)
BE (1) BE847973A (en:Method)
CA (1) CA1077942A (en:Method)
CH (3) CH624102A5 (en:Method)
DD (1) DD126942A5 (en:Method)
DE (1) DE2549999A1 (en:Method)
DK (1) DK494876A (en:Method)
FI (1) FI763148A7 (en:Method)
FR (1) FR2330678A1 (en:Method)
GB (1) GB1502050A (en:Method)
HU (1) HU171237B (en:Method)
IE (1) IE43866B1 (en:Method)
IT (1) IT1063618B (en:Method)
LU (1) LU76141A1 (en:Method)
NL (1) NL7612286A (en:Method)
SE (1) SE7612234L (en:Method)
SU (3) SU633473A3 (en:Method)
ZA (1) ZA766381B (en:Method)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FI934894L (fi) * 1991-05-07 1993-11-05 Merck & Co Inc Fibrinogenreceptorantagonister
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2144763A1 (en) * 1992-10-14 1994-04-28 George D. Hartman Fibrinogen receptor antagonists
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
KR100403246B1 (ko) * 1995-09-28 2004-02-11 가켄 세이야쿠 가부시키가이샤 ４-메틸렌피페리딘의제조방법
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
JP5405571B2 (ja) * 2008-07-24 2014-02-05 セラヴァンス， インコーポレーテッド ３−（フェノキシフェニルメチル）ピロリジン化合物
TWI461407B (zh) 2008-11-14 2014-11-21 Theravance Biopharma R & D Ip Llc 製備４－〔２－（２－氟苯氧基甲基）苯基〕哌啶化合物之方法
EP2419405A1 (en) * 2009-04-15 2012-02-22 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
EP2454234B1 (en) * 2009-07-13 2018-04-11 Theravance Biopharma R&D IP, LLC 3-phenoxymethylpyrrolidine compounds
WO2011011231A1 (en) 2009-07-21 2011-01-27 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
US8778949B2 (en) * 2010-01-11 2014-07-15 Theravance Biopharma R&D Ip, Llc 1-(2-phenoxymethylphenyl)piperazine compounds
EP2550252B1 (en) * 2010-03-22 2015-05-06 Theravance Biopharma R&D IP, LLC 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
CA2811641A1 (en) 2010-10-11 2012-04-19 Theravance, Inc. Serotonin reuptake inhibitors
WO2012075239A1 (en) 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NL7612286A (nl) 1977-05-10
SU633473A3 (ru) 1978-11-15
IE43866L (en) 1977-05-07
DD126942A5 (en:Method) 1977-08-24
HU171237B (hu) 1977-12-28
GB1502050A (en) 1978-02-22
FI763148A7 (en:Method) 1977-05-08
IE43866B1 (en) 1981-06-17
JPS6055509B2 (ja) 1985-12-05
CH627166A5 (en:Method) 1981-12-31
DE2549999A1 (de) 1977-05-12
ATA823776A (de) 1979-03-15
CH625788A5 (en:Method) 1981-10-15
BE847973A (fr) 1977-05-04
CH624102A5 (en:Method) 1981-07-15
DE2549999C2 (en:Method) 1989-01-26
US4243807A (en) 1981-01-06
SU867298A3 (ru) 1981-09-23
SU662009A3 (ru) 1979-05-05
DK494876A (da) 1977-05-08
FR2330678B1 (en:Method) 1980-11-07
AT352726B (de) 1979-10-10
JPS5259163A (en) 1977-05-16
LU76141A1 (en:Method) 1977-05-18
SE7612234L (sv) 1977-05-07
IT1063618B (it) 1985-02-11
CA1077942A (en) 1980-05-20
FR2330678A1 (fr) 1977-06-03

Similar Documents

Publication Publication Date Title
GB1516780A (en) Piperidine derivatives
ZA766381B (en) New piperidine derivatives
HK23979A (en) Piperidyl-triazine derivatives
PH12533A (en) New benzhydrylsulphinyl derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
ZA764322B (en) Novel 1-(benzazolyalkyl)piperidine derivatives
IL49706A0 (en) Novel anhydro-vinca derivatives
PT65387B (en) Novel 1-(benzazolylalkyl) piperidine derivatives
AU1597876A (en) Ortho-aminobutyrophenone derivatives
JPS5217472A (en) Substituted nnalkylimidazole derivatives
PH13356A (en) 4-(3-alkylaminopropoxy)-indolse derivatives
AU1074176A (en) Oxadiazolinone derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
CY1151A (en) Cis-bicyclooctyl-alkyl-amine derivatives
JPS5212163A (en) Novel cerotonine derivatives
GB1554720A (en) Pyridthione derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives
GB1551442A (en) 11-methylene-6-piperazinyl-morphanthridine derivatives
JPS5268183A (en) Substituted pyrandione derivatives
GB1520011A (en) Benodioxole derivatives
HK47079A (en) Enamine derivatives
JPS525749A (en) Novel bezophenone derivatives
IL49072A (en) Triazolocycloalkathiadiazine derivatives
IL48972A0 (en) Triazolocycloalkylhydrothiadiazine derivatives